Stock Events

Abbott Laboratories 

$104.37
2804
-$0.15-0.15% Friday 15:28

统计数据

当日最高
104.87
当日最低
103.59
52周最高
124.24
52周最低
93.36
成交量
5,759.36
平均成交量
67,186
市值
-
市盈率
-
股息收益率
2.11%
股息
2.2

即将到来

股息

2.11%股息收益率
10年增长
9.6%
5年增长
11.44%
3年增长
6.92%
1年增长
7.84%

收益

18Jul已确认
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
下一个
0.93
1.02
1.1
1.19
预期每股收益
1.106567
实际每股收益
N/A

人们还关注

此列表基于关注0Q15.LSE的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。
Johnson & Johnson
JNJ
市值352.53B
强生与雅培在多个领域竞争,包括医疗设备、诊断和制药,使其成为雅培多个业务线上的直接竞争对手。
Medtronic
MDT
市值99.52B
在医疗器械领域,Medtronic与Abbott竞争,尤其是心血管和糖尿病护理产品。
Thermo Fisher Scientific
TMO
市值206.16B
Thermo Fisher Scientific在诊断和生命科学领域与Abbott竞争,提供一系列分析仪器、试剂和耗材。
Danaher
DHR
市值177.21B
Danaher Corporation在诊断和生命科学行业与Abbott竞争,特别是通过其子公司Cepheid提供分子诊断解决方案。
Boston Scientific
BSX
市值112.32B
波士顿科学公司在医疗器械领域与雅培竞争,尤其是心血管产品。
Baxter International
BAX
市值17.79B
Baxter International 在医疗器械和营养领域与 Abbott 竞争,提供重症护理、营养、肾脏护理等产品。
Stryker
SYK
市值128.48B
Stryker在医疗器械领域与Abbott竞争,尤其是在骨科领域,间接与Abbott在其他医疗器械类别中竞争。
Becton Dickinson
BDX
市值65.82B
Becton, Dickinson and Company在医疗技术领域与Abbott竞争,提供设备、实验室设备和诊断产品。
Resmed
RMD
市值28.61B
ResMed通过提供用于睡眠障碍和呼吸疾病的医疗设备与Abbott在健康领域竞争,这补充了Abbott更广泛的医疗设备组合。
Hologic
HOLX
市值17.29B
Hologic在诊断领域与Abbott竞争,尤其是在妇女健康领域,两家公司都提供一系列诊断和医学成像解决方案。

关于

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Show more...
首席执行官
Mr. Robert B. Ford
员工
113000
国家
United States
ISIN
US0028241000
WKN
000850103

上市公司